The Global Tonometer Market size is expected to reach $544.6 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period.
The glaucoma patients in North America have expanded, therefore, the North America region would capture approximately 1/3rd share of the market by 2030. The presence of major competitors in the region, streamlined reimbursement procedures, and an increase in the prevalence of glaucoma is anticipated to fuel the regional market's expansion. The region is also seeing a rising prevalence of glaucoma risk factors like diabetes, myopia, and hypertension. Growing behavioral risk factors like smoking, drinking, eating poorly, and leading a sedentary lifestyle are mostly responsible for this. Some of the factors impacting the market are growing number of camps for eye examinations and glaucoma awareness campaigns, increase in the frequency of glaucoma Insufficient staff, and resources for healthcare in LMICs.
It is essentially possible to prevent vision loss and blindness by being aware of and detecting ophthalmic disorders like glaucoma that cause eye difficulties early on. As a result, raising public awareness of the condition may be crucial in its prevention, regular eye exams, and measures to ward off blindness. In addition, the campaign included a fundraising incentive that equaled every dollar received up to $20,000 in favor of the GRF study for glaucoma treatment. Such actions performed by the associations of powerful nations encourage individuals to seek regular eye exams and raise their awareness of the condition, which helps the market. According to the National Library of Medicine, with a 2.2% global frequency, primary open-angle glaucoma (POAG) is thought to affect 57.5 million individuals worldwide. The prevalence of POAG in Europe is 2.51%, affecting 7.8 million people. In the UK, POAG is the most widespread form of glaucoma, affecting 2% of people over 40 and 10% of people over 75, primarily people of African and Caribbean descent. Therefore, the increasing prevalence of glaucoma has raised serious concerns regarding the overall health of individuals, which in turn is driving the demand for tonometers.
However, despite political and financial commitment at the international, regional, national, and district levels, the majority of LMICs (low- and middle-income countries) in the rest of the world still have unmet needs and insufficient funding for health care. The National Library of Medicine reports that only five of the 21 sub-Saharan African countries evaluated today have ophthalmologists who fulfill WHO requirements, and by 2020, it is not anticipated that the situation will change. Contrarily, none of the 21 countries had the recommended number of optometrists, and only four of the 21 countries had enough ophthalmologists to care for a million patients. Therefore, the lack of infrastructure in such areas may limit the market's expansion.
Based on type, the market is characterized into applanation tonometer, rebound tonometer, indentation tonometer, and pascal dynamic contour tonometer. The applanation tonometer segment garnered the highest revenue share in the market in 2022. The introduction of technologically upgraded tonometers with enhanced diagnostic precision and patient comfort elements aids in the segment's expansion. The test known as applanation tonometry gauges the fluid pressure inside the eye. In essence, the test evaluates the amount of pressure required to temporarily flatten a portion of the cornea. It is utilized in the glaucoma diagnosing process.
Based on end-use, the market is segmented into hospitals, ophthalmic centers, and others. The hospitals segment garnered a remarkable growth rate in the market in 2022. For eye therapy, hospitals can either have a general department or a dedicated ophthalmology clinic, which necessitates the large-scale acquisition of tonometer testing equipment. The segment is anticipated to expand significantly throughout the projected period of time as glaucoma care costs are paid in various nations, including the United States and Germany.
By portability, the market is divided into desktop and handheld. The handheld segment recorded a significant revenue share in the market in 2022. Commercially available portable tonometers include the tono-pen, rebound tonometer, and Perkins tonometer. The factors anticipated to propel the growth of the segment in the coming years are the portable tonometer's portability, ease of use, and improved patient comfort. These are utilized in places where there are more patients. They are more frequently used in IOP screening because they are portable, easy to use, and provide accurate findings.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 355.5 Million |
| Market size forecast in 2030 | USD 544.6 Million |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 5.6% from 2023 to 2030 |
| Number of Pages | 221 |
| Number of Table | 350 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Type, Portability, End-use, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment acquired a substantial revenue share in the market in 2022. The development of the regional market is anticipated, particularly in developing nations like India and China, where rapid urbanization and rising glaucoma awareness will play a role. The Asia Pacific market is anticipated to rise over the course of the forecast period as a result of significant unmet healthcare demands, expanding healthcare infrastructure, and rising life expectancy.
Free Valuable Insights: Global Tonometer Market size to reach USD 544.6 Million by 2030
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Keeler Ltd. (Halma plc), Topcon Corporation, Revenio Group Oyj (Icare Finland Oy), Reichert, Inc. (Ametek, Inc.), OCULUS Optikgerate GmbH, Kowa American Corporation (Kowa Company, Ltd.), Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, Canon, Inc. (Canon Medical Systems Corporation), and Tomey Corporation
By Type
By End-Use
By Portability
By Geography
The Market size is projected to reach USD 544.6 million by 2030.
An increase in the frequency of glaucoma are driving the Market in coming years, however, Insufficient staff and resources for healthcare in LMICs restraints the growth of the Market.
Keeler Ltd. (Halma plc), Topcon Corporation, Revenio Group Oyj (Icare Finland Oy), Reichert, Inc. (Ametek, Inc.), OCULUS Optikgerate GmbH, Kowa American Corporation (Kowa Company, Ltd.), Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, Canon, Inc. (Canon Medical Systems Corporation), and Tomey Corporation.
The expected CAGR of this Market is 5.6% from 2023 to 2030.
The Ophthalmic Centers segment is leading the Market by End-use in 2022; thereby, achieving a market value of $298.8 million by 2030.
The North America region dominated the Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $188.6 million by 2030.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
